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Cultured human skin fibroblasts from control persons and from patients with the generalized and late- 
onset forms of Pompe’s disease were labelled with radioactive leucine and the incorporation of radio- 
activity into acid cY-glucosidase and cathepsin D was analysed by immunoprecipitation, gel electrophoresis 
and fluorography. When the labelling was carried out for 6- 12 h in the presence of NH&l, the labelling 
of secreted cu-glucosidase r lative to that of secreted cathepsin D in fibroblasts from patients with the late- 
onset form of Pompe’s disease was < 15% of that in fibroblasts from control persons. However, when 
the fibroblasts were labelled for < 1 h, the relative rate of incorporation of radioactivity into acid a-gluco- 
sidase was rather similar in the two types of fibroblasts. In fibroblasts from patients with the generalized 
form of Pompe’s disease no incorporation of radioactivity into acid cy-glucosidase could be detected. 
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1. INTRODUCTION (5-20% of normal) is present in patients with the 
late-onset form [6-lo]. 
Glycogenosis type II (Pompe’s disease) is an in- 
born error of metabolism in man in which a defi- 
ciency of acid cu-glucosidase leads to accumulation 
of glycogen in the lysosomes [ 11. The disease is 
clinically heterogeneous [2]. In the infantile or 
generalized form glycogen storage is observed in 
most organs and the patients die within the first 2 
years of life [2]. In the late-onset or muscular form 
glycogen storage is observed mainly in skeletal 
muscles and death occurs several years after the 
onset of the disease [2]. The infantile form is 
characterized by a complete absence of acid a- 
glucosidase [1,2] and, in most cases, of cross- 
reactive immunological material [3-71. On the 
other hand, residual acid cu-glucosidase activity 
Enzymological and physicochemical properties 
of the residual acid a-glucosidase in cultured skin 
fibroblasts [6] and in urine [lo] from patients with 
the late-onset form of the disease are indistinguish- 
able from those of the enzyme from control per- 
sons. These studies indicate that patients with the 
late-onset form of the disease have a smaller 
number of acid a-glucosidase molecules than nor- 
mal persons. This reduction may be due either to 
decreased synthesis or to enhanced breakdown of 
acid a-glucosidase in the patients [6]. 
Enzymes: cathepsin D (EC 3.4.23.5); a-glucosidase 
(EC 3.2.1.20) 
In cultured human skin fibroblasts, acid cu-glu- 
cosidase is synthesized via a precursor with M, 
-95 000 which is subsequently converted to smaller 
products [ 11,121. Neither the precursor nor the 
product could be detected in fibroblasts from pa- 
tients with the infantile form of glycogenosis type 
II [ 1 I]. Here, we present results on the synthesis of 
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acid cr-glucosidase in fibroblasts from patients 
with different forms of glycogenosis type II. Some 
of the results have been presented in abstract form 
u31. 
2. MATERIALS AND METHODS 
L-[4,5-3H]Leucine (spec. act. 50 Ci/mmol), L- 
[35S]methionine (spec. act. 1200Ci/mmol) and 
[r4C]methylated standards were from New Eng- 
land Nuclear. Immunoprecipitin, a formalin fixed 
Stuphylococcus A cell wall suspension (10%) was 
from Bethesda Research Labs. Antiserum against 
human liver acid cu-glucosidase was raised in a 
rabbit [lo] and against human placental cathepsin 
D in a goat [ll]. 
2.1. Cell lines and culture 
The fibroblast cell lines 80RD174, 261, M and B 
were from control persons; 266 and 248LAD were 
from patients with the infantile form of Pompe’s 
disease; and G, H, 338LAD and 77RD89 (referred 
to as RD89 in fig. 2) were from patients with the 
late-onset form of Pompe’s disease. 
Human diploid skin fibroblasts were maintained 
at 37°C under 5% CO2 in Eagle’s minimal essential 
medium supplemented with antibiotics, non-essen- 
tial amino acids and lo!70 fetal calf serum (Boehr- 
inger Mannheim GmbH) as in [14]. Fibroblasts 
from patients affected with glycogenosis type II 
were kindly provided by Professor Martinus 
Niermeijer (Division of Clinical Genetics, Erasmus 
University, Rotterdam) and Dr Kurt Ullrich 
(Universitats-Kinderklinik, Miinster). 
2.2. Metabolic label/kg and isolation of lysoso- 
mal enzymes 
Cells grown to confluency in 25 or 75 cm2 tissue 
culture flasks were depleted of either leucine or 
methionine and incubated in a radioactive medium 
as in [ll]. The apparent rate of synthesis of 
lysosomal enzymes was measured as incorporation 
of radioactivity in immunoprecipitable material in 
secretions obtained in the presence of 1OmM 
NH&I (see [15] for rationale) or in cells after a 
short labelling period (10 min pulse and 5 min 
chase) to avoid degradation in lysosomes or en 
route to lysosomes, respectively. Immunoprecipi- 
tates were solubilized in 1% SDS-IO mM 
dithiothreitol and analysed by gel electrophoresis 
70 
and fluorography as in [l 11. Immunoprecipitates 
of cells and medium were prepared as in [ 1 l] ex- 
cept when cells were pulse-labelled for 10 min. In 
the latter case samples were suspended in 1% 
Nonidet NP40, 1% sodium deoxycholate, 0.14M 
NaCl and 1OmM sodium phosphate (pH 7.4). 
After clarification of the extract by centrifugation 
for 1 h at 45000 x g, cu-glucosidase was im- 
munoprecipitated using 0.5yg purified enzyme as 
carrier. After removal of the immune complexes, 
the supernatant was processed for im- 
munoprecipitation of cathepsin D, as follows. Two 
volumes of immunoprecipitin were added and 
after 30 min the suspension was centrifuged for 1 h 
at 45000 x g. The supernatant was mixed with 0.8 
vol of buffered detergent (1% Triton X-100, lolo 
SDS, 0.5% sodium deoxycholate, 5 mg/ml bovine 
serum albumin, 1OmM sodium phosphate (pH 7.4) 
and 0.14 M NaCl). Affinity purified anti-cathepsin 
D antibodies (8Opg immunoglobin able to 
precipitate 2.7pg cathepsin D directly) were added 
and after 0.5 h at 22°C and 3 16 h at 4°C 140~1 im- 
munoprecipitin was added. After 0.5 h at 4*C with 
occasional gentle mixing, the cell walls were spun 
down in an Eppendorf centrifuge (30s) and wash- 
ed once with 0.5 ml cold buffered detergent and 
twice with 0.5 ml cold 0.14M NaCl-10mM 
sodium phosphate (pH 7.4). The adsorbed antigen 
was solubilized by incubating the immunoprecipi- 
tin with 70~1 of a solution containing 1% SDS, 
1OmM dithiothreitol, 10% glycerol and 125mM 
Tris-HCl (pH6.8) for 5min at 95°C. After 
removal of immunoprecipitin by centrifugation, 
the supernatant was subjected to electrophoresis as 
in [15]. 
The radioactivity in the bands was quantified as 
in [15]. 
3. RESULTS AND DISCUSSION 
When fibroblasts from patients with the late- 
onset form of Pompe’s disease were cultured in the 
presence of [3H]leucine for 16h, or pulse-labelled 
for 1 h with [35S]methionine and chased for 24 h, a 
pattern of immunoprecipitated a-glucosidase 
polypeptides was obtained which closely resembled 
that of polypeptides immunoprecipitated from 
normal cells (fig. 1; see [ 111). These polypeptides 
could not be detected in fibroblasts from patients 
with the infantile form of Pompe’s disease (fig. l), 
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Fig. 1. Incorporation of radioactivity into cu-glucosidase and cathepsin D in fibroblasts from control persons and pa- 
tients with different forms of Pompe’s disease. Lanes: (l-6) labelling for 16 h with 0.2 mCi [3H]leucine; (8-l 1) cells 
labelled for 1 h with 0.2 mCi [35S]methionine and chased for 24 h in medium free of radioactivity. The ratio of media 
and cell extracts used for immune precipitation of cu-glucosidase was 2: 1. Abbreviations: C, cells; M, medium. 
in agreement with [ll]. Fig. 1 shows that here is 
a difference in the intensity of the labelling of (Y- 
glucosidase polypeptides (but not cathepsin D 
polypeptides) in adult Pompe’s disease fibroblasts. 
To study the rate of formation of the precursor 
of Lu-glucosidase, fibroblasts were cultured for 
various times in the presence of [3H]leucine 
together with NH&l; in the presence of certain 
weak bases like NH&l the processing of the 
precursors of lysosomal enzymes is prevented and 
the precursors accumulate in the medium 
[ 11,12,16- 181. The results of a typical experiment 
are presented in fig. 2. Only the precursor forms of 
acid a-glucosidase and cathepsin D, and not the 
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Fig. 2. Radioactivity in acid a-glucosidase and cathepsin D in medium after culture of fibroblasts for various times with 
0.4 mCi [3H]leucine and 1OmM NH&l. cy-Glucosidase and cathepsin D were immunoprecipitated from 9/10 and l/10 
aliquots of the medium, respectively. 
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processed forms, were found in the medium, in 
agreement with [ 111. The cr-glucosidase polypep- 
tide in the medium of adult Pompe’s disease fibro- 
blasts had the same M, as that in control fibro- 
blasts but was present in lower concentrations. No 
a-glucosidase polypeptides could be detected in the 
medium of the infantile Pompe fibroblasts. 
The increase in incorporated radioactivity with 
time was quantified as in [15]. Table 1 shows that 
the rate of secretion of the precursor of cy- 
glucosidase relative to that of the precursor of 
cathepsin D in adult Pompe fibroblasts was 
3-10% of that in control fibroblasts. In this ex- 
periment , incorporation of radioactivity into 
cathepsin D in the medium was lower than that 
usually observed. However, a similar picture 
emerged when arylsulphatase A was used as the 
reference enzyme. 
Analogous results have been described in [19]; 
fibroblasts were cultured in the presence of NH&l 
and measured acid cu-glucosidase activity in the 
Table 1 
Rate of appearance in medium of radioactively abelled 
precursors of cu-glucosidase and cathepsin D during 
culture of fibroblasts in the presence of [‘Hlleucine and 
10mM NH&l 
Cell line Rate of incorporation of 
[3H]leucine (cpm/h) into 
precursor of 
A/B 
Acid cu-gluco- Cathep- 
sidase (A) sin D (B) 
Controls 
80RD174 95 170 0.56 




266LAD CO.5 186 c 0.003 




77RD89 9 132 0.068 
338LAD 12 182 0.066 
H. 3 152 0.020 
Data from fig. 1 
medium; the rate of appearance of the activity in 
the medium in mutant fibroblasts was -10% of 
that in control fibroblasts. 
The reduced secretion of newly synthesized a- 
glucosidase in adult Pompe fibroblasts was not due 
to retention of the enzyme in the cells; in the 
presence of 10 mM NH&l, the same proportion of 
newly synthesized a-gluosidase (-50070) was found 
intracellularly in control fibroblasts (see also [l 11) 
as in adult Pompe fibroblasts. It should be noted 
that the proportion of newly synthesized (Y- 
glucosidase found intracellularly when fibroblasts 
were cultured in the presence of 10 mM NHdCl was 
higher than that of newly synthesized ,& 
hexosaminidase (< 20%; see also [l 11) or 
arylsulphatase A (< 25 070). 
The results presented so far indicated that net 
formation of the precursor of acid cu-glucosidase 
was reduced in fibroblasts from patients with the 
late-onset form of Pompe’s disease. The question 
arose of whether this was due to a reduction in the 
rate of synthesis of acid a-glucosidase or to 
enhanced breakdown of newly synthesized en- 
zyme. We therefore incubated fibroblasts with 
[35S]methionine, in the absence of NH&l, for a 
Table 2 
Incorporation of radioactivity into cr-glucosidase and 
cathepsin D in various fibroblast lines after a 10min 
pulse with 0.6 mCi [“S]methionine followed by a 5 min 
chase 
Cell line Radioactivity (cpm) in A/B 
Acid cr-gluco- Cathep- 
sidase (A) sin D (B) 
Control 
80RD174 23 336 0.068 
Infantile 
Pompe 
266 cl 511 c 0.002 
248LAD cl 452 c 0.002 
Late-onset 
Pompe 
338LAD 19 692 0.027 
H. 21 983 0.021 
c. 14 344 0.041 
For experimental details see section 2 
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Fia. 3. Radioactivity in acid cr-glucosidase and cathepsin D in fibroblasts after a 10min pulse with 0.6mCi 
W[35S]methionLe and a 5 min chase. For experimental details see section 2. 
relatively short period (10 min pulse + 5 min 
chase). The results of a typical experiment are 
shown in fig. 3. The M, of the radioactive CY- 
glucosidase polypeptide was the same in adult 
Pompe fibroblasts as in control fibroblasts. Fur- 
thermore, the difference in the intensity of the cr- 
glucosidase band in adult Pompe and control 
fibroblasts was much less than in the experiments 
where cells were pulsed for 3-16 h (cf. fig. 1,2). In- 
deed, the quantification in table 2 shows that the 
initial rate of synthesis of cu-glucosidase in adult 
Pompe fibroblasts was 30-60% of that in control 
cells. In an experiment in which cells were pulse- 
labelled with [35S]methionine for 0.5, 1, 1.5 and 2 h 
the amount of 3’S-labelled cr-glucosidase relative to 
that of 35S-labelled cathepsin D in an adult Pompe 
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cell line (338LAD) was 70, 85,40 and 30070, respec- 
tively, of that in a control line (80RD174). Similar 
results were obtained when the incorporation of 
radioactivity into a-glucosidase was related to that 
into arylsulphatase A. 
The stability of acid a-glucosidase in lysosomes 
has been estimated by allowing purified enzyme to 
be endocytosed by fibroblasts from patients with 
the infantile form of Pompe’s disease and 
monitoring the enzyme activity in the cells [ 191. a- 
Glucosidase purified from fibroblasts from pa- 
tients with the late-onset form of Pompe’s disease 
had about the same half-life as that from secre- 
tions of control fibroblasts [19]. 
4. CONCLUDING REMARKS 
Three observations suggested that the rate of 
synthesis of a-glucosidase may be much lower in 
fibroblasts from patients with the late-onset form 




The residual enzyme activity is low (5-20070 of 
that in controls [6-lo]; 
The amount of radioactivity recovered in pro- 
cessed cr-glucosidase after prolonged incuba- 
tion is low (< 15% of that in controls; this 
paper); 
The rate of NH&l-induced secretion of 
radioactively labelled precursor is < 15% of 
that in controls (table 1). 
However, the results of the short-time incubations 
(< 1 h) described here indicate that the residual rate 
of formation of u-glucosidase in the mutant fibro- 
blasts is 30-85% of that in control fibroblasts, 
which is in apparent contradiction to the three 
observations above. This apparent discrepancy 
may be explained by assuming that the LY- 
glucosidase initially synthesized in fibroblasts from 
patients with the late-onset form of Pompe’s 
disease has a decreased stability in compartments 
that are located proximal to the site where am- 
monium chloride interferes with the segregation of 
lysosomal enzymes. In compartments distal to this 
site, the enzyme appears to be stable (fig. 1 and 
[191)- 
In fibroblasts from patients with the generalized 
form of Pompe’s disease no incorporation of 
radioactivity into a-glucosidase could be detected. 
In these fibroblasts either no protein im- 
munologically related to cY-glucosidase is synthesiz- 
ed or it is broken down immediately after 
synthesis. 
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